Figure 5.

Growth inhibition of HuCC-T1 cells by treatment of sorafenib-incorporated DexbLG nanoparticles. Two thousand cells were exposed to sorafenib, empty nanoparticles, and sorafenib-incorporated nanoparticles for 48 h.

Kim et al. Nanoscale Research Letters 2012 7:91   doi:10.1186/1556-276X-7-91
Download authors' original image